Multifunctional immune cell therapies
AssigneeArcellx, Inc.
InventorsDavid M. HILBERT, Jeffrey S. SWERS, David William LAFLEUR
Life of this patent
Estimating the term…
Abstract
Provided herein are multi-functional chimeric antigen receptor (CAR)-based compositions and their use in directing immune responses to target cells. The compositions have uses that include treating hyperproliferative disorders such as cancer. The provided methods generally include the use of a CAR cell in combination with an Adapter. The Adapter confers the ability to modulate, alter, and/or redirect CAR cell-mediated immune response in vitro and in vivo. In some embodiments, the CAR cell comprises a genetic modification to reduce or eliminate the expression of a targeted antigenic determinant
Claims14
1-27. (canceled)
A method of treating a subject suffering from an autoimmune disease, the method comprising:
- administering to the subject suffering from the autoimmune disease an effective amount of a cell engineered to express a chimeric antigen receptor (CAR), wherein the CAR comprises a target-binding domain comprising a D domain target-binding domain;
- wherein the D domain specifically binds BCMA and comprises the amino acid sequence of any one of SEQ ID NO:
- 44-339.
Dependencies are inferred from the claim text.